Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Philippe Colson et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 and the cardiovascular system
Ying-Ying Zheng et al.
NATURE REVIEWS CARDIOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases
Tao Ai et al.
RADIOLOGY (2020)
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu et al.
INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Alfred H. J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
Andre C. Kalil
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Potential Effects of Coronaviruses on the Cardiovascular System A Review
Mohammad Madjid et al.
JAMA CARDIOLOGY (2020)
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
A Randomized Trial of Epinephrine in Out-of-Hospital Cardiac Arrest
G. D. Perkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection
Pierre Roques et al.
VIRUSES-BASEL (2018)
Hydroxychloroquine retinopathy - implications of research advances for rheumatology care
April Jorge et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models
Rodrigo Delvecchio et al.
VIRUSES-BASEL (2016)
Chloroquine inhibited Ebola virus replication in vitro but failed to protect against infection and disease in the in vivo guinea pig model
Stuart D. Dowall et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Lack of Protection Against Ebola Virus from Chloroquine in Mice and Hamsters
Darryl Falzarano et al.
EMERGING INFECTIOUS DISEASES (2015)
On Chikungunya Acute Infection and Chloroquine Treatment
Xavier De Lamballerie et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2008)
Chloroquine is effective against influenza A virus in vitro but not in vivo
David J. Vigerust et al.
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2007)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
ACE2: from vasopeptidase to SARS virus receptor
AJ Turner et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Share Paper
